Humacyte, Inc. Public Float
Humacyte, Inc. (HUMA) had Public Float of $280.30 million as of 2025-06-30, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-27
- 2025-06-30: Entity Public Float $280.30M.
- 2024-06-30: Entity Public Float $453.20M.
- 2023-06-30: Entity Public Float $178.20M.
- 2022-06-30: Entity Public Float $165.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $280.30M 10-K · filed 2026-03-27 |
| 2024-06-30 | $453.20M 10-K · filed 2025-03-31 |
| 2023-06-30 | $178.20M 10-K · filed 2024-03-28 |
| 2022-06-30 | $165.90M 10-K · filed 2023-03-24 |
| 2021-06-30 | $102.40M 10-K · filed 2022-03-29 |
| 2020-12-31 | $102.20M 10-K/A · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |